SEC Form 4 · accession 0001193125-26-330507
Apnimed, Inc. · APMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul J Sekhri
Director
Period of report
Jul 30, 2026
Accepted (ET)
Aug 3, 2026 · 4:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001745648
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 3, 2026 | P | 12,500 | $16.00 | A | 12,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $8.15 | Aug 3, 2026 | D | 169,468 | D | — | May 28, 2036 | Class A Common Stock | 169,468 | 0 | D |
| Stock Option (Right to Buy)F2 | $8.15 | Aug 3, 2026 | A | 169,468 | A | — | May 28, 2036 | Common Stock | 169,468 | 169,468 | D |
| Stock Option (Right to Buy)F2 | $16.00 | Jul 30, 2026 | A | 155,558 | A | — | Jul 29, 2036 | Class A Common Stock | 155,558 | 155,558 | D |
| Stock Option (Right to Buy)F2 | $16.00 | Aug 3, 2026 | D | 155,558 | A | — | Jul 29, 2036 | Class A Common Stock | 155,558 | 0 | D |
| Stock Option (Right to Buy)F2 | $16.00 | Aug 3, 2026 | A | 155,558 | A | — | Jul 29, 2036 | Common Stock | 155,558 | 155,558 | D |
| Stock Option (Right to Buy)F3 | $16.00 | Jul 30, 2026 | A | 22,238 | A | — | Jul 29, 2036 | Class A Common Stock | 22,238 | 22,238 | D |
| Stock Option (Right to Buy)F3 | $16.00 | Aug 3, 2026 | D | 22,238 | D | — | Jul 29, 2036 | Class A Common Stock | 22,238 | 0 | D |
| Stock Option (Right to Buy)F3 | $16.00 | Aug 3, 2026 | A | 22,238 | A | — | Jul 29, 2036 | Common Stock | 22,238 | 22,238 | D |
Explanation of responses
- F1Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock.
- F2One-third of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 24 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
- F3The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.